An Official Website of the United States Government
Company Information:
Name:
SEQUOIA SCIENCES, INC.
Address:
SEQUOIA SCIENCES, INC.
1912 INNERBELT BUSINESS CENTER DR
SAINT LOUIS, MO 63114-5760
1912 INNERBELT BUSINESS CENTER DR
SAINT LOUIS, MO 63114-5760
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Rapid Identificatioin of Regulators of Apoptosis
Award Year / Program / Phase:
2001 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Lu Zeng
Award Amount:
$170,495.00
Abstract:
DESCRIPTION (provided by applicant): Inappropriate activation or inactivation
of apoptosis (programmed cell death) can have devastating consequences, from
neurodegenerative disease to cancer. This Phase I proposal tests the hypothesis
that we can significantly increase the… More
Control of Biofilms by Natural Products
Award Year / Program / Phase:
2001 / STTR / Phase I
Agency:
HHS
Research Institution:
MONTANA STATE UNIVERSITY
Abstract:
DESCRIPTION (provided by applicant): The importance of Biofilms in chronic and
treatment-resistant infectious disease, increasingly is clear. Biofilms also
are a major problem in industrial processes. The focus of this proposal is to
develop methods for discovering compounds… More
Novel Nematicides Exist as Minor Components in Plants
Award Year / Program / Phase:
2005 / SBIR / Phase I
Agency:
USDA
Principal Investigator:
Gary R. Eldridge, President and Chief Scientific Officer
Award Amount:
$80,000.00
Abstract:
Preliminary data confirm that novel nematicidal compounds exist in libraries of plant compounds. This project will screen libraries to discover and indentify novel nematicides.
The next generation of synthetically-accessible anticancer drugs exist at minor c
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Gary R. Eldridge
Award Amount:
$120,572.00
Abstract:
DESCRIPTION (provided by applicant): Treating cancer is clearly a very difficult process, and while progress has been made, much work remains to be done. The failures of many seemingly promising compounds to meet expectations have taught us that we must ag
gressively continue to develop new,… More